MedTrace Logo

Expressive Writing for Co-Occurring Depression and Alcohol Misuse

NCT00818636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2015-01-27

No results posted yet for this study

Summary

\*\*\*Please note that this study does not offer comprehensive treatment program for alcohol abuse or depression. Please do not contact the study staff if you are seeking psychological treatment. Further, this study is only enrolling people who are clients at Career and Recovery Resources, Inc., in Houston.

The hypothesis is that writing about feelings and thoughts will help people who are in group treatment feel less depressed and abuse alcohol less.

Conditions

Interventions

BEHAVIORAL

Expressive writing (in addition to group therapy as usual).

Participants in the expressive writing condition write about their feelings about an issue of their choosing three times, for at least 20 minutes each time, during a two week period.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Carrie L Dodrill, Ph.D. · The University of Texas Health Science Center at Houston- ** This contact information should not be used for counseling or informational purposes**

  • Angela L Stotts, Ph.D. · The University of Texas Health Science Center at Houston- ** This contact information should not be used for counseling or informational purposes**

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-03-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00818636 on ClinicalTrials.gov